Glyxambi, a medication used to treat type 2 diabetes, is not available in the Philippines through Mercury Drug [1]. Glyxambi combines empagliflozin and linagliptin to help manage blood sugar levels [2].
How much does Glyxambi cost?
The price of Glyxambi varies significantly by region and insurance coverage. In the United States, for example, the average retail price for a 30-day supply can range from $400 to $500, though manufacturer coupons and patient assistance programs may reduce out-of-pocket costs [3]. Without insurance, the cost can be substantially higher [3]. Specific pricing information for other countries is not readily available through general sources.
Where can I buy Glyxambi?
Glyxambi is available by prescription in countries where it has received regulatory approval. In the United States, it can be obtained through most major retail pharmacies. Availability in other countries depends on local pharmaceutical regulations and distribution networks. As noted, it is not currently distributed by Mercury Drug in the Philippines [1].
What is Glyxambi used for?
Glyxambi is prescribed as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus [2]. It works by helping to lower blood sugar levels through two different mechanisms: empagliflozin, which is an SGLT2 inhibitor, and linagliptin, which is a DPP-4 inhibitor [2].
Are there alternatives to Glyxambi?
Yes, there are numerous alternative medications and treatment strategies for type 2 diabetes. These include other SGLT2 inhibitors, DPP-4 inhibitors, metformin, sulfonylureas, GLP-1 receptor agonists, and insulin therapy [4]. The choice of treatment depends on individual patient factors, including other medical conditions, kidney function, and tolerance to specific medications [4].
What are the patents for Glyxambi?
Glyxambi, as a fixed-dose combination, has patent protection covering the specific formulation and its use [5]. Patent expiry dates are crucial for determining when generic versions of the drug might become available, potentially lowering costs [5]. Information on specific patent expiry for Glyxambi can be found through resources like DrugPatentWatch.com [5].
What are the side effects of Glyxambi?
Common side effects of Glyxambi can include upper respiratory tract infections, diarrhea, and urinary tract infections [2]. More serious, though less common, side effects can include pancreatitis, hypoglycemia (especially when used with a sulfonylurea), hypersensitivity reactions, and a risk of bladder cancer [2]. Patients should discuss any concerns about side effects with their healthcare provider.
What is the difference between empagliflozin and linagliptin?
Empagliflozin is an SGLT2 inhibitor that works in the kidneys to prevent the reabsorption of glucose, leading to increased glucose excretion in the urine [2]. Linagliptin is a DPP-4 inhibitor that works in the pancreas and gut to increase levels of incretin hormones, which in turn increase insulin secretion and decrease glucagon secretion [2]. Glyxambi combines these two active ingredients to provide a dual mechanism for blood sugar control.
Why is Glyxambi not available in the Philippines?
The availability of a drug in a specific country depends on several factors, including the drug manufacturer's decision to seek regulatory approval from local health authorities and establish distribution channels [1, 6]. If Glyxambi has not been approved by the Philippine Food and Drug Administration (FDA) or if the manufacturer has not launched it there, it will not be available through local pharmacies [6].
Sources:
[1] Mercury Drug Philippines. https://www.mercurydrug.com/
[2] Glyxambi Prescribing Information. https://www.glyxambi.com/
[3] GoodRx. https://www.goodrx.com/glyxambi
[4] American Diabetes Association. https://www.diabetes.org/
[5] DrugPatentWatch.com. https://www.drugpatentwatch.com/
[6] Philippine Food and Drug Administration. https://www.fda.gov.ph/